Our researchers have developed a molecule that can be administered nasally to inactivate the coronavirus spike protein and offers effective short-term protection, according to cell cultures & animal studies. #HelsinkiUni #COVID19 #research @HelsinkiUniMed https://t.co/LnsYkAQw1P
— University of Helsinki (@helsinkiuni) January 10, 2022 10:30